Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 127 | |||||
| (NASDAQ: AXSM) | Delayed: 144.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.06 | 52 Week High | $15.74 | |||
| Open | $144.06 | 52 Week Low | $5.37 | |||
| Day High | $144.06 | P/E | N/A | |||
| Day Low | $144.06 | EPS | $0.00 | |||
| Volume | 62 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 1.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.87 | 52 Week High | $4.66 | |||
| Open | $1.87 | 52 Week Low | $2.01 | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $0.00 | |||
| Volume | 5 | |||||



